Seyedeh Maryam Bashiri, MD
Family Practice · Greenbrae
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 16 years
- Graduated 2010
Offices
2 locations · Galen Inpatient Physicians PC · Providence Medical Foundation
Looking this up.
Hospitals listed: Marinhealth Medical Center · Providence Santa Rosa Memorial Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bashiri’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A166072 · Current
Licensed to practise in California · since 2019 · expires 2027-10-31 · University of Szeged Albert Szent-Gyorgyi Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
- American Board of Family Medicine - Geriatric Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$81,889
Medicare paid this office $81,889 for 356 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 256 | $56,551 | $94 |
| Hospital discharge day management, more than 30 minutes | 187 | $18,075 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $4,952 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,172 | $65 |
Who their Medicare patients are
356 Original Medicare patients in 2024. Average age 75 · Under 65 10% · 85 and older 19% · Women 48% · Also on Medicaid 38% · Health risk score 2.26. Sicker patients than 9 in 10 peers; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Heart failure 44% · Coronary heart disease 43% · Chronic kidney disease 42% · Diabetes 41% · Depression 38% · Atrial fibrillation 36% · COPD 33% · Stroke 25% · Cancer 21% · Dementia 21%.
The office billed $332,790, Medicare allowed $105,612 and paid $81,889; for 862 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 356 | 862 | 75 | 2.26 | $332,790 | $81,889 |
| 2023 | 401 | 1,027 | 76 | 2.31 | $263,918 | $90,248 |
| 2022 | 378 | 1,184 | 77 | 2.12 | $308,299 | $96,291 |
| 2021 | 382 | 651 | 74 | 2.44 | $511,266 | $76,778 |
| 2020 | 122 | 179 | 75 | 2.50 | $160,908 | $18,947 |
| 2019 | 84 | 108 | 72 | 1.62 | $74,438 | $7,870 |
| 2018 | 21 | 23 | 75 | 1.70 | $13,601 | $1,882 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 259 | $48,733 | $97 |
| Hospital discharge day management, more than 30 minutes | 187 | $17,813 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $13,374 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $5,786 | $135 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,364 | $107 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $1,595 | $41 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 294 | $66,815 | $82 |
| Hospital discharge day management, more than 30 minutes | 153 | $13,901 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 77 | $8,465 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,249 | $162 |
| Hospital observation care on day of discharge | 15 | $906 | $60 |
2021: 6 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 163 | $29,413 | $167 |
| Initial hospital observation care per day, typically 70 minutes | 141 | $21,382 | $151 |
| Advance care planning, first 30 minutes | 186 | $13,108 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $5,246 | $87 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 28 | $2,389 | $85 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,011 | $92 |
2020: 6 services
| Initial hospital observation care per day, typically 70 minutes | 31 | $4,946 | $160 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,757 | $176 |
| Advance care planning, first 30 minutes | 39 | $2,714 | $70 |
| Emergency department visit with high level of medical decision making | 17 | $2,264 | $133 |
| Emergency department visit with moderate level of medical decision making | 13 | $1,281 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,207 | $55 |
2019: 2 services
| Emergency department visit with moderate level of medical decision making | 43 | $3,703 | $86 |
| Initial hospital observation care per day, typically 50 minutes | 11 | $1,124 | $102 |
Medicaid work
$23,329 in 2024
Medicaid paid $23,329 for 500 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 428 | $18,855 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 72 | $4,475 |
| 2024 | 500 | 2 | 30 | $23,329 |
| 2023 | 611 | 3 | 28 | $28,851 |
| 2022 | 629 | 2 | 32 | $25,427 |
| 2021 | 140 | 2 | 24 | $8,423 |
| 2020 | 29 | 1 | 15 | $2,952 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 430 | $20,739 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 73 | $4,105 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 108 | $4,007 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 577 | $22,750 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 52 | $2,678 |
2021
| 1ST HOSP IP/OBS HIGH 75 | 97 | $6,076 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 43 | $2,347 |
2020
| 1ST HOSP IP/OBS HIGH 75 | 29 | $2,952 |
Drugs they prescribed that Part D paid
$14,704
Pharmacies billed $14,704 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
185 generic and fewer than 11 brand-name prescriptions · $14,704 in drug cost · 51 antibiotic prescriptions to 39 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $8,340 | $758 |
| Pantoprazole | 15 | $212 | $14 |
| Metoprolol | 17 | $109 | $6 |
Year by year
| 2024 | 213 | 101 | None | None | $14,704 |
| 2023 | 204 | 97 | None | None | $17,092 |
| 2022 | 191 | 79 | None | None | $15,092 |
| 2021 | 58 | 12 | 0% (0) | None | $1,977 |
| 2020 | 157 | 36 | 0% (0) | None | $8,215 |
| 2019 | 1,279 | 102 | None | 20% | $103,048 |
| 2018 | 1,285 | 116 | None | None | $108,399 |
| 2017 | 852 | 108 | None | None | $59,910 |
| 2016 | 154 | 40 | 0% (0) | None | $9,804 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Amoxicillin-Clavulanate Potass | 16 | $234 | $15 |
2022: 2 drugs
| Amoxicillin-Clavulanate Potass | 12 | $117 | $10 |
| Prednisone | 18 | $97 | $5 |
2021: 1 drug
| Valproic Acid | 13 | $488 | $38 |
2020: 4 drugs
| Valproic Acid | 11 | $454 | $41 |
| Gabapentin | 11 | $146 | $13 |
| Atorvastatin | 12 | $120 | $10 |
| Amlodipine Besylate | 14 | $98 | $7 |
2019: 34 drugs
| Tresiba Flextouch U-200 | 32 | $16,203 | $506 |
| Trulicity | 11 | $8,867 | $806 |
| Lantus Solostar | 19 | $8,213 | $432 |
| Tradjenta | 28 | $5,990 | $214 |
| Novolog | 13 | $4,024 | $310 |
| Carbamazepine Er | 16 | $1,462 | $91 |
| Gabapentin | 75 | $1,460 | $19 |
| Metoprolol | 51 | $1,243 | $24 |
| Atorvastatin | 69 | $780 | $11 |
| Ventolin Hfa | 13 | $751 | $58 |
| Chlorthalidone | 14 | $738 | $53 |
| Rosuvastatin | 17 | $439 | $26 |
| Lisinopril | 46 | $389 | $8 |
| Memantine | 18 | $380 | $21 |
| Fluticasone Propionate | 22 | $335 | $15 |
| Pravastatin | 21 | $330 | $16 |
| Allopurinol | 32 | $329 | $10 |
| Amlodipine Besylate | 62 | $318 | $5 |
| Metoprolol | 24 | $268 | $11 |
| Hydrochlorothiazide | 38 | $251 | $7 |
| Simvastatin | 31 | $247 | $8 |
| Potassium Chloride | 19 | $245 | $13 |
| Omeprazole | 35 | $241 | $7 |
| Metformin | 44 | $234 | $5 |
| Metformin Hcl Er | 21 | $211 | $10 |
| Losartan | 24 | $210 | $9 |
| Levothyroxine | 18 | $169 | $9 |
| Clopidogrel | 14 | $165 | $12 |
| Losartan-Hydrochlorothiazide | 14 | $156 | $11 |
| Donepezil | 29 | $149 | $5 |
| Furosemide | 28 | $145 | $5 |
| Carvedilol | 22 | $131 | $6 |
| Montelukast | 22 | $113 | $5 |
| Lisinopril-Hydrochlorothiazide | 13 | $49 | $4 |
2018: 35 drugs
| Tresiba Flextouch U-200 | 34 | $18,275 | $537 |
| Lantus Solostar | 14 | $5,553 | $397 |
| Carbamazepine Er | 13 | $2,435 | $187 |
| Proair Hfa | 13 | $1,086 | $84 |
| Ventolin Hfa | 16 | $942 | $59 |
| Metoprolol | 31 | $890 | $29 |
| Gabapentin | 42 | $650 | $15 |
| Pravastatin | 25 | $529 | $21 |
| Triamcinolone Acetonide | 47 | $496 | $11 |
| Omeprazole | 60 | $411 | $7 |
| Rosuvastatin | 19 | $401 | $21 |
| Potassium Chloride | 22 | $387 | $18 |
| Atorvastatin | 37 | $359 | $10 |
| Metformin | 40 | $355 | $9 |
| Memantine | 12 | $320 | $27 |
| Lisinopril | 37 | $310 | $8 |
| Pantoprazole | 27 | $310 | $11 |
| Amlodipine Besylate | 69 | $257 | $4 |
| Simvastatin | 35 | $203 | $6 |
| Metoprolol | 28 | $198 | $7 |
| Montelukast | 18 | $174 | $10 |
| Furosemide | 38 | $164 | $4 |
| Losartan-Hydrochlorothiazide | 13 | $156 | $12 |
| Amlodipine Besylate-Benazepril | 13 | $147 | $11 |
| Losartan | 28 | $139 | $5 |
| Hydralazine | 15 | $129 | $9 |
| Donepezil | 24 | $126 | $5 |
| Carvedilol | 20 | $121 | $6 |
| Glimepiride | 18 | $114 | $6 |
| Metformin Hcl Er | 23 | $111 | $5 |
| Ranitidine | 11 | $84 | $8 |
| Hydrochlorothiazide | 23 | $73 | $3 |
| Sertraline | 11 | $72 | $7 |
| Lisinopril-Hydrochlorothiazide | 21 | $55 | $3 |
| Prednisone | 14 | $45 | $3 |
2017: 24 drugs
| Tresiba Flextouch U-200 | 19 | $10,907 | $574 |
| Ketoconazole | 14 | $1,009 | $72 |
| Rosuvastatin | 15 | $869 | $58 |
| Gabapentin | 53 | $843 | $16 |
| Metoprolol | 44 | $772 | $18 |
| Metformin | 22 | $248 | $11 |
| Lisinopril | 25 | $194 | $8 |
| Omeprazole | 38 | $189 | $5 |
| Atorvastatin | 21 | $187 | $9 |
| Pravastatin | 11 | $172 | $16 |
| Triamcinolone Acetonide | 14 | $134 | $10 |
| Simvastatin | 19 | $130 | $7 |
| Pantoprazole | 12 | $123 | $10 |
| Allopurinol | 13 | $118 | $9 |
| Montelukast | 12 | $104 | $9 |
| Furosemide | 22 | $98 | $4 |
| Hydrochlorothiazide | 25 | $95 | $4 |
| Metoprolol | 13 | $87 | $7 |
| Amlodipine Besylate | 28 | $75 | $3 |
| Meloxicam | 26 | $65 | $2 |
| Ranitidine | 12 | $63 | $5 |
| Prednisone | 14 | $52 | $4 |
| Losartan | 16 | $48 | $3 |
| Pramipexole Dihydrochloride | 11 | $40 | $4 |
2016: 2 drugs
| Omeprazole | 11 | $48 | $4 |
| Metoprolol | 11 | $34 | $3 |
Money from drug and device companies
$106 in 2022
A payment is not proof that care is biased.
| Abbott Laboratories | Cardiomems | $106 | 1 payment
|
See the published payment
| Abbott Laboratories | Meals · 2022-03-25 | Cardiomems | $106 |
Professional record
- NPI
- 1477900850
- Licence
- CA A166072California A166072: Current · expires 2027-10-31
- Group
- Galen Inpatient Physicians PC · Providence Medical Foundation
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Hospitalist (208M00000X); Family medicine (207Q00000X); Federal specialty code 207QG0300X (207QG0300X); Student in a training program (390200000X)
- Mailing address
- 4010 S Mulberry St, Pine Bluff, AR, 71603
- NPI first listed
- 2016-05-16
- NPI last updated
- 2021-11-08
- NPI record certified
- 2021-11-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1165 Montgomery Dr, Santa Rosa, CA, 95405